Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Antineoplastic Agents > Somatulina for Sale > Sichuan Duorui - Lanreotide Acetate
Sichuan Duorui - Lanreotide Acetate buy - large image1
Sichuan Duorui - Lanreotide Acetate buy - image1

Sichuan Duorui - Lanreotide Acetate

GMP FDA COA

Unit Price: Get Latest Price
CAS No.:

127984-74-1

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Chengdu

Packaging:

depends on customers' needs

Price valid (until):

2026-02-28

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Semaglutide,Tirzepatide,Retatrutide,Lanreotide Acetate,Pegcetacoplan

  • Product Description

  • Seller Information

  • History Price

  • Description

    Lanreotide Acetate API
    Indication: Carcinoid Syndrome & Acromegaly
    Batch Size: 5kg
    SSA more than50 ㎡/g
    Form a unique nanostructuremeet the sustained-release requirements of the formulation

    Please feel free to contact us if you need product COA.

    Contact Person:Delia Zhong

    Wechat/Tel:  +86 184 8235 1102

    E-mail:deliazhong@duoruipharm.com

    Website:https://www.duoruibiopharm.com

    Certificates

    Basic Info
    Product Name:

    Somatulina

    Other Name:

    10-(4-aminobutyl)-19-[(2-amino-3-naphthalen-2-yl-propanoyl)amino]-N-(1 -carbamoyl-2-hydroxy-propyl)-16-[(4-hydroxyphenyl)methyl]-13-(1H-indol -3-ylmethyl)-6,9,12,15,18-pentaoxo-7-propan-2-yl-1,2-dithia-5,8,11,14, 17-pentazacycloicosane-4-carboxamide;Somatulina;3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2→7)-disulfide acetate;Angiopeptin acetate

    CAS No.:

    127984-74-1

    Molecular Formula:

    C54H69N11O10S2

    InChIKeys:

    PUDHBTGHUJUUFI-UHFFFAOYSA-N

    Molecular Weight:

    1096.3 g/mol

    Exact Mass:

    1155.488159

    Categories:

    Antineoplastic Agents

    Characteristics
    PSA:

    406 Ų

    Appearance:

    white to off-white

    Storage Conditions:

    -20°C

    Hazard Identification

    Classification of the substance or mixture

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Semaglutide,Tirzepatide,Retatrutide,Lanreotide Acetate,Pegcetacoplan

    Location:

    No. 76 Jinle Road, Chengdu-Aba Industrial Concentration Development Zone, Jintang County, Chengdu City, Sichuan Province, China

    Payment Terms:

    TT against copy of documents,L/C,100% TT in advance

    Total Annual Revenue:

    $5 million-$10 million

    Total Employees:

    101-200

    Year of Establishment:

    2018

    Established in 2018 and located in Jintang County, Chengdu, Sichuan Province, focuses on the R&D and production of peptide APIs. The company covers an area of ​​200,000 square meters, has a GMP production workshop, possesses advanced peptide drug preparation technology, and has large-scale peptide production capabilities, providing high-quality, low-cost, and fast-response product services.

    Main products: Lanreotide Acetate, Semaglutide, Tirzepatide, Retatrutide, Teriparatide, etc.

    Capacity:
    Peptide for human use: 500 kg
    Peptide for Veterinary use: 200 kg

    Oct., 2024: "Albuvirtide" API passed the NMPA GMP compliance inspection.
    Aug. 2023: "Teriparatide" Injection"assembly line passed US FDA site inspection with no 483 observation.

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.